Chalet Hotels has received a certificate confirming compliance with the SEBI (Depositories and Participants) Regulations for the quarter ended September 30, 2025. The company confirms that KFin Technologies Limited, the Registrar and Share Transfer Agent, provided the certificate, stating no requests for dematerialization or rematerialization of securities were received during the quarter.

Compliance Certificate Received

Chalet Hotels has announced the receipt of a certificate concerning compliance with specific SEBI regulations. This certificate pertains to the Depositories and Participants Regulations and covers the period ending September 30, 2025.

Details of the Certificate

The certificate, provided by KFin Technologies Limited, the company’s Registrar and Share Transfer Agent, confirms that no requests for dematerialization or rematerialization of the company’s securities were received during Q2 (Jul-Sep) of 2025. The company is fulfilling its compliance requirements by informing the stock exchanges.

Source: BSE

Afcons Infrastructure has confirmed the fulfillment of its payment obligations regarding the redemption of commercial paper worth Rs. 25 crores. This announcement, dated October 13, 2025, pertains to commercial paper under the SEBI Master Circular.

Commercial Paper Redemption Completed

Afcons Infrastructure confirms the company has successfully fulfilled its payment obligations concerning the redemption of its commercial paper. The total value of the commercial paper redeemed is Rs. 25 crores. This update was formally announced on October 13, 2025.

Details of Redemption

The redemption pertains to commercial paper with ISIN INE101I14EN9, which matured on October 13, 2025.

Source: BSE

Hero MotoCorp, the world’s largest two-wheeler manufacturer, has officially entered the Italian market through a distribution partnership with Pelpi International. This marks Hero MotoCorp’s 49th international market. The company will offer Euro 5+ compliant models and aims to redefine the future of mobility with smart solutions. Initial distribution will focus on key cities with a plan to expand across Italy.

Hero MotoCorp Debuts in Italy

Hero MotoCorp announced its official entry into Italy on October 13, 2025. This expansion marks the company’s 49th international market. The distribution of Hero MotoCorp products will be managed by Pelpi International, one of Italy’s largest distributors.

Partnership and Distribution

Pelpi International will manage the distribution, offering sales, service, and parts across Italy through a network of 160+ dealers. The initial distribution will concentrate on key cities with 36+ dealers, with plans to expand to 54.

Brand Philosophy: You Are Limitless

Hero MotoCorp is launching in Italy with the philosophy “You Are Limitless.” This celebrates the spirit of today’s riders and embodies freedom and determination.

Flagship Models

The three flagship models being introduced are the Xpulse 200 4V, Xpulse 200 4V Pro, and Hunk 440. These models are E5+ and EU-compliant.

Hunk 440 Details

The Hunk 440 enters the L3e-A2 performance category, designed for city commuting and motorway acceleration. Its engine delivers 36.0 Nm of torque at 4000 rpm and a net power of 27 BHP at 6000 rpm. The bike is equipped with dual-channel ABS, USD Cartridge Forks by KYB, a full-digital & connected TFT display, and 150/60 ZR 17 radial tyres.

The Hunk 440 starts at €3.990 (Incl. VAT) and is offered in Twilight Blue and Phantom Black.

Xpulse 200 Family

The Xpulse 200 4V Pro features a powerful 4-Valve head producing 18.9 BHP and 17.35 Nm of torque. It includes three ABS Modes (Road, Off-road, and Rally), a digital speedometer, and LED Projector headlamps.

The Xpulse 200 4V is priced at €2.990, and the Xpulse 200 4V Pro at €3.190.

Warranty and Assurance

Hero MotoCorp offers a standard 3-year warranty. An additional 2-year warranty will be offered as part of a special launch promotion, bringing the total warranty to 5 years (T&Cs applied).

Source: BSE

RHI Magnesita India Limited confirms compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The certificate from Skyline Financial Services Private Limited, the Registrar and Share Transfer Agent, confirms the dematerialization of securities for the quarter ended September 30, 2025. All share certificates have been duly processed, mutilated, and cancelled, with the depository’s name substituted in records.

Share Dematerialization Confirmation

RHI Magnesita India Limited has received confirmation regarding compliance with share dematerialization regulations. This relates to the handling of physical share certificates received for dematerialization, specifically as it pertains to the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Compliance for Quarter Ended September 30, 2025

A certificate was issued by Skyline Financial Services Private Limited, the Registrar and Share Transfer Agent, stating that for the quarter ended September 30, 2025, all procedures related to the dematerialization of shares have been completed. This includes the processing of physical share certificates received from depository participants.

Certificate Details

The certificate confirms that securities comprised in the share certificates have been listed on the Stock Exchange where the earlier securities were listed. Furthermore, all share certificates, after due verification, have been mutilated and cancelled, with the name of the depository substituted in the records as registered owner within 15 days. The certificate is dated October 3, 2025.

Source: BSE

Supreme Industries has received a certificate concerning the dematerialization of securities for the quarter ended September 30, 2025. The registrar and share transfer agent, Bigshare Services Pvt. Ltd., confirmed that securities received from depository participants for dematerialization were processed. The security certificates were mutilated and cancelled after due verification.

Confirmation of Dematerialization

Supreme Industries has received confirmation regarding the processing of securities for dematerialization during the quarter ended September 30, 2025. The certificate was provided by Bigshare Services Pvt. Ltd., the company’s Registrar and Share Transfer Agent.

Details of Compliance

Bigshare Services Pvt. Ltd. certified that all securities received from Depository Participants for dematerialization up to September 30, 2025, were duly confirmed and processed. This confirms that all securities have been listed on the Stock Exchanges where the initial securities were listed.

Post-Dematerialization Actions

The certificate also confirms that all received security certificates have been mutilated and cancelled following verification by the Depository Participant. Furthermore, the Depositories’ names have been substituted in the Register of Members as registered owners within 15 days of receiving the certificate of securities.

Source: BSE

Eris Lifesciences has confirmed the dematerialization of securities for the quarter ended September 30, 2025. The confirmation, received from MUFG Intime India Private Limited, indicates that securities received for dematerialization have been processed and confirmed with the depositories. All related security certificates have been duly mutilated and cancelled, with depositories registered as owners.

Dematerialization Confirmation

Eris Lifesciences confirms the successful processing of securities received for dematerialization during the quarter ending September 30, 2025. This confirmation aligns with regulatory requirements for depositories and participants. The confirmation was received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA) for Eris Lifesciences.

Regulatory Compliance

The confirmation ensures compliance with regulations concerning the dematerialization process. MUFG Intime India Private Limited has verified and confirmed the securities, ensuring all procedures are followed correctly.

Details of the Process

As part of the process, security certificates received for dematerialization have been confirmed, and subsequently mutilated and cancelled. The depositories have been registered as the new owners.

Source: BSE

Dr. Reddy’s Laboratories will release its Q2FY26 results on Friday, October 24th, 2025, following the Board Meeting. An earnings call has been scheduled for the same day at 19:30 PM IST / 10:00 AM ET to discuss the company’s financial performance. Pre-registration for the earnings call is available through the provided link.

Q2FY26 Results Announcement

Dr. Reddy’s Laboratories Ltd. will announce its financial results for the quarter and six months ended September 30th, 2025 (Q2FY26) on Friday, October 24th, 2025, after the Board Meeting.

Earnings Call Details

Following the release of the results, the management of Dr. Reddy’s will host an earnings call to discuss the company’s financial performance. The earnings call is scheduled for Friday, October 24th, 2025, at 19:30 PM IST / 10:00 AM ET.

Accessing Further Information

The release of financial results will be accessible through various channels, including the stock exchange, media outlets, the company website, and via email. A press meet presentation and an audio transcript of the earnings call will be available on the company’s website at www.drreddys.com.

Earnings Call Registration

Interested parties can pre-register for the earnings call using the following link: https://drreddys.zoom.us/webinar/register/WN_UsxFnaCVRaiV-KhZsVDuFQ

Source: BSE

Lupin Limited presented Phase 1 clinical trial data for LNP3693, a STING agonist, at the ESMO Congress in Berlin from October 17-21, 2025. The data provides insights into the safety and anti-tumor activity in patients with solid tumors. The presentation, titled ‘A phase 1 dose escalation study of LNP3693…’, was featured in the Investigational Immunotherapy session. This presentation is another milestone for Lupin.

Lupin Presents LNP3693 Data

Lupin Limited announced the presentation of data from its Phase 1a clinical trial evaluating LNP3693, a STING agonist, at the ESMO Congress in Berlin, Germany. The presentation occurred between October 17 and October 21, 2025.

Details of the Presentation

The presentation, titled “A phase 1 dose escalation study of LNP3693 (STING agonist) in patients with advanced or metastatic solid tumors & lymphoma,” was featured in the Investigational Immunotherapy session (Presentation Number 1553P). It was available for viewing on October 19, 2025, from 09:00 to 17:00 CEST.

About LNP3693

LNP3693 is an investigational parenteral STING agonist. The presentation provided qualitative insights into its safety, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity in patients with solid tumors.

Executive Commentary

Vinita Gupta, CEO, Lupin, stated, “This marks another important milestone for us. Following our successful presentation of LNP7457, a PRMT5 inhibitor, at ASCO in June 2025, it is a privilege to present the findings of another Phase 1 clinical trial for LNP3693, a STING agonist, at ESMO. ESMO’s acknowledgment of the clinical research conducted in India underscores the proficiency of our team in oncology drug discovery, research, and clinical development.”

ESMO Congress 2025 Details

Complete data has been provided for presentation at the ESMO Congress 2025 and addressed during the official session. All abstracts accepted for presentation were published online on October 13. They will also be published in the ESMO Congress 2025 Abstract Book.

Source: BSE

Action Construction Equipment Limited has received a certificate under regulation 74(5) of the SEBI regulations for the quarter ended September 30, 2025. The certificate was issued by the Registrar and Share Transfer Agents, Skyline Financial Services Private Limited, and confirms compliance with regulations related to depositories and participants.

Certificate of Compliance

Action Construction Equipment Limited announced that a certificate has been issued concerning compliance with SEBI regulations for the second quarter of fiscal year 2026 (July-September 2025). The certificate, dated October 9, 2025, was provided by Skyline Financial Services Private Limited, the Registrar and Share Transfer Agent for the company.

Details of the Certificate

The certificate confirms adherence to regulation 74(5) of the relevant SEBI regulations concerning depositories and participants. Skyline Financial Services Private Limited verified that securities have been duly listed on the stock exchange and that share certificates received for dematerialization have been processed, mutilated, and cancelled as required, with the depository’s name substituted in the records within 15 days.

Source: BSE